Rezvoglar™ (insulin glargine-aglr) injection

3 mL (100 units/mL)

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Is the formulation of Rezvoglar™ (insulin glargine‑aglr) and Basaglar® (insulin glargine) the same?

Rezvoglar and Basaglar are insulin glargine 100 units/mL products that have the same formulation.

US_cFAQ_REZ022_FORMULATION_VS_BASAGLAR
cFAQ
cFAQ
US_cFAQ_REZ022_FORMULATION_VS_BASAGLAR
en-US

Formulations of Rezvoglar and Basaglar

The inactive ingredients used in the formulation of Rezvoglar™ (insulin glargine‑aglr) 100 units/mL are the same as those in Basaglar® (insulin glargine) 100 units/mL (Excipients Contained in Rezvoglar and Basaglar Prefilled Pens).1,2

Excipients Contained in Rezvoglar and Basaglar Prefilled Pens1,2

Inactive Ingredient

Rezvoglar

Basaglar

Zinc oxide, mcg/mL

30

30

Metacresol, mg/mL

2.7

2.7

Glycerin, mg/mL

17

17

Hydrochloric acid 10%

For pH adjustmenta

Sodium hydroxide 10%

For pH adjustmenta

Water for Injection, USP

Q.S. to 1 mL

Abbreviations: Basaglar = Basaglar® (insulin glargine) 100 units/mL; Q.S. = quantum sufficit; Rezvoglar = Rezvoglar™ (insulin glargine‑aglr) 100 units/mL; USP = United States Pharmacopeia.

aThe pH is approximately 4.

References

1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

2Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

Date of Last Review: April 04, 2022


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical